(Health-NewsWire.Net, June 14, 2018 ) Global Cell-Based Assay Market 2018-2023:
The global cell-based assay market is expected to register a CAGR of 8.2% during the forecast period of 2018–2023. Cell-based assays are versatile research lab tool in healthcare, designed to target specific cells using antibodies or other moieties, to determine the functionality and efficacy of drugs. The higher expenditure on R&D, favorable government initiatives, and more technological advancements help North America to dominate this market.
Major players: BECTON, DICKINSON AND COMPANY, BIO-RAD LABORATORIES, INC., CORNING, INC., DANAHER CORPORATION, DISCOVERX CORPORATION, F. HOFFMANN-LA ROCHE LTD, MERCK KGAA, PERKIN ELMER, INC., PROMEGA CORPORATION, AND THERMO FISHER SCIENTIFIC, INC., amongst others.
Get Sample Copy of Global Cell-Based Assay Market @ http://orbisresearch.com/contacts/request-sample/2131421
Becton, Dickinson And Company, Bio-Rad Laboratories, Inc., Corning, Inc., Danaher Corporation, Discoverx Corporation, F. Hoffmann-La Roche Ltd, Merck Kgaa, Perkin Elmer, Inc., Promega Corporation, Thermo Fisher Scientific, Inc.
Rising Chronic Diseases and Lifestyle Disorders
The rising prevalence of chronic diseases and lifestyle disorders, such as cancer, arthritis, cardiovascular, diabetes, and epilepsy, is one of the primary factors for the growth of this market. The cell-based assays for nervous system and chronic pain drug discovery provide new opportunities in the search for novel medicines for neurodegenerative diseases and pain. Cell-based assays are highly useful in screening mutagenesis in case of various types of cancers, such as chronic myeloid leukemia. According to the Center for Disease Control and Prevention, seven of the top 10 diseases in 2014 were chronic diseases. Thus, the rise in chronic diseases provides rising demand for cell-based assays for newer drug discoveries, making it a vital factor for the growth of this market.
Other factors playing a vital role for the growth of this market include increasing investments in R&D for drug discovery, technological advancements in cell-based methodologies, and rising adoption of high-throughput screening methods, particularly in toxicological studies.
High Maintenance and Operational Costs
One of the major factors restraining the cell-based assays market is the high maintenance of instruments and their operational costs. With the involvement of significant cost in operations, the market becomes less attractive in large-scale applications. For example, high cost associated with the CellKey system and RT-CES. With that, there is an increased cost for coated plates, which are not readily affordable. This forces several companies and research labs to find cost-effective alternatives, such as pre-treating of plates with collagen, thereby, impeding the growth of the market.
Along with this, other factors such as lack of skilled professionals and stringent regulatory pathways linked to instruments, reagents, and kits hamper the growth of this market.
United States to Hold the Largest Market Share
The United States is expected to have the largest market share in the forecast period. The dominance is primarily attributed to the rising availability of funds for research and extensive drug discovery activities in the country from multinational firms in collaborations with domestic companies and research institutes. The Asia-Pacific region also posses a potential market for the growth of cell-based assays due to a large patient pool, rising economies, and rising assays applications, with China and India being profitable markets.
Enquire Before Buying Global Cell-Based Assay Market Report @ http://orbisresearch.com/contacts/enquiry-before-buying/2131421
Key Developments in the Market
February 2018: Imec, one of the leaders in nanoelectronics and digital technologies, designed and fabricated a 16,384-electrode, 1,024-channel micro-electrode array for high-throughput multi-modal cell interfacing.
January 2018: Agilent Technologies expanded its cell analysis portfolio by the acquisition of Luxcel Biosciences, involved in the development of real-time fluorescence plate-reader based on in-vitro cell assay kits.
Reasons to Purchase the Report
A look at the current and future of the global cell-based assays market in the developed and emerging regions.
Analyzing various perspectives of the market with the help of Porter’s Five Forces Analysis.
Identify the segment that is expected to dominate the market.
Identify the regions that are expected to witness the fastest growth during the forecast period.
Identify the latest developments, market shares, and strategies employed by the major market players.
3 months analyst support along with the Market Estimate sheet (in Excel).
Customization of the Report
This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
Table Of Content:
2. Research Approach and Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
Place Purchase Order for Global Cell-Based Assay Market Report @ http://orbisresearch.com/contact/purchase/2131421
+1 (214) 884-6817